Acute Chest Pain Imaging in the ED With the Combine CCTA and CT Perfusion
NCT02538861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2022-04-20
Summary
This is a prospective open label two arms clinical trial. ARM-A patients will receive the standard of care diagnostic test at Baptist Hospital Main (BHM), which includes Single Photon Emission Computed Tomography (SPECT) imaging, while ARM-B patients will be randomized sequentially into two groups; Group-1 will receive CT Angiography and CT myocardial perfusion with new Revolution CT scanner (General Electric Healthcare) while the Group-2 will receive SPECT imaging test; both groups of ARM-B at West Kendall Baptist Hospital (WKBH). The primary hypothesis is that the combined evaluation of CT angiography with CT myocardial perfusion is more efficient in detecting or excluding acute coronary syndrome resulting in early discharge and decrease length of stay of patients from the Emergency Department (ED) compared to a strategy with SPECT alone. The secondary hypothesis is that a strategy with CTA/CTP can reduce direct patient care costs and potentially improve patient outcomes in the same patient population when compared to a strategy with SPECT imaging alone.
The main purpose of this study is to have a definite ED chest pain admission triage, which will help to reduce the length of stay and direct patient cost. This approach will reduce the economic burden in intermediate risk group patients as well. We had a Baptist statistician run the numbers. This study will provide important preliminary data to guide clinical implementation of CTP/CTA in clinical practice. We divided arm B into two groups as the CT protocol might be different at each hospital, so we want to reduce bias as a result of variation in clinical patterns in the different hospitals. Also, we kept 50 patients in arm A (Baptist hospital) to have a control group at the hospital level.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
SPECT Imaging Test at Baptist hospital
Single Photon Emission Tomography (SPECT) testing at Baptist Hospital.
- DIAGNOSTIC_TEST
-
CT Angiography and CT myocardial perfusion at West Kendall Baptist Hospital
The combined approach of CT Angiography and CT myocardial perfusion with new Revolution CT scanner
- DIAGNOSTIC_TEST
-
SPECT Imaging Test at West Kendall Baptist Hospital
Single Photon Emission Tomography (SPECT) testing at West Kendall Baptist hospital.
Sponsors & Collaborators
-
GE Healthcare
collaborator INDUSTRY -
Baptist Health South Florida
lead OTHER
Principal Investigators
-
Ricardo C Cury, MD · Baptist Health South Florida
Eligibility
- Min Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2019-06-06
- Completion
- 2019-06-06
Countries
- United States
Study Locations
More Related Trials
-
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
NCT01384448 ·Status: COMPLETED ·Phase: NA
-
Coronary CT Angiography in Acute Chest Pain is a Cost Effective Risk Stratification Strategy
NCT00825435 ·Status: COMPLETED ·Phase: PHASE3
-
CArdiac cT in the Treatment of Acute CHest Pain 2 - Myocardial CT Perfusion
NCT02014311 ·Status: COMPLETED ·Phase: NA
-
Coronary Computed Tomographic Angiography in Intermediate-risk Chest Pain Patients
NCT04748237 ·Status: RECRUITING ·Phase: NA
-
The Miami Heart Study at Baptist Health South Florida
NCT02508454 ·Status: ACTIVE_NOT_RECRUITING
-
Coronary Computed Tomographic Angiography in Emergency Department Chest Pain Patients at Intermediate Risk of Acute Coronary Syndrome
NCT00473863 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Multicenter Study for Early Evaluation of Acute Chest Pain
NCT04122573 ·Status: UNKNOWN
-
Myocardial Stress Perfusion Computed Tomography in the Evaluation of Patients With Acute Chest Pain Using a Novel 3rd Generation Dual-source CT System
NCT02308475 ·Status: TERMINATED ·Phase: NA
-
Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography
NCT03952351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)
NCT02280941 ·Status: COMPLETED ·Phase: NA
-
Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
NCT02284191 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Acute Cardiac Care
NCT02355457 ·Status: RECRUITING
-
Magnetocardiography Using a Novel Analysis System (Cardioflux) in the Evaluation of Emergency Department Observation Unit Chest Pain Patients
NCT03255772 ·Status: COMPLETED
-
Rule Out Myocardial Infarction by Computer Assisted Tomography
NCT00990262 ·Status: COMPLETED
-
Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain
NCT00380094 ·Status: COMPLETED
-
CT-FIRST: Cardiac Computed Tomography Versus Stress Imaging For Initial Risk STratification
NCT01061398 ·Status: UNKNOWN ·Phase: NA
-
Cardiac SPECT With Rotating Slant Hole Collimator
NCT00328315 ·Status: COMPLETED
-
High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification
NCT02984436 ·Status: COMPLETED
-
Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eLevation myocARdial Infarction Using the HEART-score With a Troponin Point-of-care Test
NCT04851418 ·Status: UNKNOWN
-
Cardiology-Emergency Medicine Cardiac Biomarker Research Initiative
NCT01984853 ·Status: COMPLETED
-
Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department
NCT00907231 ·Status: WITHDRAWN
-
PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy
NCT04538950 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)
NCT00892307 ·Status: COMPLETED
-
Improving the Accuracy of Referrals of Patients With Chest Pain
NCT04904107 ·Status: UNKNOWN ·Phase: NA
-
MRI Evaluation of Chest Pain
NCT00001961 ·Status: COMPLETED ·Phase: PHASE2